The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106947785 10694778 5 F 20140716 20160818 20150107 20160823 EXP JP-JNJFOC-20141220111 JANSSEN 67.73 YR E M Y 63.00000 KG 20160823 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106947785 10694778 1 PS SOVRIAD SIMEPREVIR 1 Oral N 205123 100 MG CAPSULE QD
106947785 10694778 2 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 600 MG UNSPECIFIED QD
106947785 10694778 3 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 400 MG UNSPECIFIED QD
106947785 10694778 4 SS RIBAVIRIN. RIBAVIRIN 1 Oral Y 0 200 MG UNSPECIFIED QD
106947785 10694778 5 SS PEGASYS PEGINTERFERON ALFA-2A 1 Subcutaneous Y 0 180 UG INJECTION /wk
106947785 10694778 6 C REZALTAS AZELNIDIPINEOLMESARTAN MEDOXOMIL 1 Oral 0 1 DF TABLET QD
106947785 10694778 7 C JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 0 50 MG TABLET QD
106947785 10694778 8 C FLUITRAN TRICHLORMETHIAZIDE 1 Oral 0 .5 DF TABLET QD
106947785 10694778 9 C ATORVASTATIN CA 2 Oral 0 10 MG TABLET QD
106947785 10694778 10 C YODEL SENNA LEAF 1 Oral 0 2 DF TABLET QD
106947785 10694778 11 C URSODEOXYCHOLIC ACID URSODIOL 1 Oral 0 300 MG TABLET QD
106947785 10694778 12 C TEPRENONE TEPRENONE 1 Oral 0 150 MG CAPSULE QD
106947785 10694778 13 C LOCHOL FLUVASTATIN SODIUM 1 Oral 0 200 MG TABLET QD
106947785 10694778 14 C LOXOPROFEN SODIUM LOXOPROFEN SODIUM 1 Oral 0 60 MG TABLET QD
106947785 10694778 15 C REBAMIPIDE REBAMIPIDE 1 Oral 0 100 MG TABLET QD
106947785 10694778 16 C POLAPREZINC POLAPREZINC 1 Oral 0 150 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106947785 10694778 1 Chronic hepatitis C
106947785 10694778 2 Chronic hepatitis C
106947785 10694778 3 Chronic hepatitis C
106947785 10694778 4 Chronic hepatitis C
106947785 10694778 5 Chronic hepatitis C
106947785 10694778 6 Hypertension
106947785 10694778 7 Diabetes mellitus
106947785 10694778 8 Hypertension
106947785 10694778 9 Hyperlipidaemia
106947785 10694778 10 Constipation
106947785 10694778 11 Prophylaxis
106947785 10694778 12 Prophylaxis
106947785 10694778 13 Prophylaxis
106947785 10694778 14 Prophylaxis
106947785 10694778 15 Prophylaxis
106947785 10694778 16 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
106947785 10694778 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106947785 10694778 Anaemia
106947785 10694778 Hyperuricaemia
106947785 10694778 Malaise
106947785 10694778 Rash
106947785 10694778 Renal impairment
106947785 10694778 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106947785 10694778 1 20140709 20140930 0
106947785 10694778 2 20140709 20140902 0
106947785 10694778 3 20140903 20140917 0
106947785 10694778 4 20141001 20141223 0
106947785 10694778 5 20140709 20141217 0
106947785 10694778 12 20140709 20140723 0
106947785 10694778 13 20140709 20140723 0
106947785 10694778 14 20140709 20140716 0
106947785 10694778 15 20140709 20140716 0
106947785 10694778 16 20141126 20141223 0